These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30248692)

  • 1. [Not Available].
    Lenz F; Bauer M; Ritter P
    Fortschr Neurol Psychiatr; 2018 Sep; 86(9):592-603. PubMed ID: 30248692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine.
    Vandel P; Sechter D; Weiller E; Pezous N; Cabanac F; Tournoux A; Panconi E
    Hum Psychopharmacol; 2004 Dec; 19(8):585-6. PubMed ID: 15570574
    [No Abstract]   [Full Text] [Related]  

  • 3. Problems with currently available antidepressants.
    Gumnick JF; Nemeroff CB
    J Clin Psychiatry; 2000; 61 Suppl 10():5-15. PubMed ID: 10910012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
    Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
    CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination treatment of depression].
    Høiseth G; Solberg DK; Refsum H
    Tidsskr Nor Laegeforen; 2012 May; 132(10):1239-41. PubMed ID: 22669385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digging for data on harms in duloxetine trials.
    Doshi P; Zito J; dosReis S
    BMJ; 2014 Jun; 348():g3578. PubMed ID: 24904123
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: a single-blind, randomized clinical trial.
    Taner E; Demir EY; Cosar B
    Adv Ther; 2006; 23(6):974-87. PubMed ID: 17276965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports.
    Madhusoodanan S; Alexeenko L; Sanders R; Brenner R
    Ann Clin Psychiatry; 2010 Aug; 22(3):148-56. PubMed ID: 20680187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results.
    Kasper S; Pletan Y; Solles A; Tournoux A
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():35-9. PubMed ID: 8923125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
    Ishigooka J
    Nihon Rinsho; 2001 Aug; 59(8):1523-9. PubMed ID: 11519152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burning paresthesia related to duloxetine therapy.
    Woo YS; Bahk WM
    J Clin Psychopharmacol; 2014 Jun; 34(3):392-4. PubMed ID: 24633002
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
    Crawford AA; Lewis S; Nutt D; Peters TJ; Cowen P; O'Donovan MC; Wiles N; Lewis G
    Psychopharmacology (Berl); 2014 Aug; 231(15):2921-31. PubMed ID: 24525810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ABCs of antidepressants. SSRIs, SNRIs, NDRIs: what's the difference?
    Health After 50 Sci Am Consum Health; 2016 Feb; 27(15):1-2. PubMed ID: 27062755
    [No Abstract]   [Full Text] [Related]  

  • 15. Finding the right antidepressant medication.
    Johns Hopkins Med Lett Health After 50; 2000 Oct; 12(8):6-7. PubMed ID: 11002753
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey.
    Williams VS; Baldwin DS; Hogue SL; Fehnel SE; Hollis KA; Edin HM
    J Clin Psychiatry; 2006 Feb; 67(2):204-10. PubMed ID: 16566614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of milnacipran: an overview.
    Montgomery SA; Prost JF; Solles A; Briley M
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():47-51. PubMed ID: 8923127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressants and side effects.
    Carter G
    Aust N Z J Psychiatry; 1995 Jun; 29(2):337. PubMed ID: 7487802
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonergic mechanisms and the new antidepressants.
    Stahl SM
    Psychol Med; 1993 May; 23(2):281-5. PubMed ID: 8332642
    [No Abstract]   [Full Text] [Related]  

  • 20. [Individualized treatment with antidepressants].
    Köhler S; Arndt A; Sterzer P; Bschor T
    Fortschr Neurol Psychiatr; 2013 Feb; 81(2):104-16; quiz 117-8. PubMed ID: 23412962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.